Ernesto Maddaloni

Pubblicazioni

Titolo Pubblicato in Anno
IFN-α neutralizing antibodies distinguish LADA from early-onset type 1 diabetes THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM 2025
Residual C-peptide secretion is associated with better CGM-metrics in adults with short-lasting type 1 diabetes DIABETES RESEARCH AND CLINICAL PRACTICE 2025
AUGMENTed Real-World Data Enhances Comparative Efficacy Between Once-Weekly Insulin Icodec with Dosing Guide App Versus Once-Daily Insulin Glargine U300 in Insulin-Naive Type 2 Diabetes DIABETES THERAPY 2025
Cardiac autonomic neuropathy is associated with ectopic fat distribution in autoimmune but not in type 2 diabetes CARDIOVASCULAR DIABETOLOGY 2025
Searching the Crystal Ball for Tailored GLP‐1 Receptor Agonists Treatment in Type 2 Diabetes and Obesity DIABETES/METABOLISM RESEARCH AND REVIEWS 2025
Osteocalcin is inversely associated with worse adipose tissue distribution and cardiovascular risk in autoimmune diabetes DIABETES RESEARCH AND CLINICAL PRACTICE 2025
Preferences, Expectations and Attitudes on Basal Insulin from Patient–Physician–Payer Perspective: A Multi-stakeholder Survey by the Italian Diabetes Society (ITA4P Study) DIABETES THERAPY 2025
Risk factors for bone fractures in type 2 diabetes and the impact of once-weekly exenatide: insights from an EXSCEL post-hoc analysis DIABETES RESEARCH AND CLINICAL PRACTICE 2025
Saxagliptin/dapagliflozin is non‐inferior to insulin glargine in terms of β‐cell function in subjects with latent autoimmune diabetes in adults: A 12‐month, randomized, comparator‐controlled pilot study DIABETES, OBESITY AND METABOLISM 2024
Immune checkpoint modulators in early clinical development for the treatment of type 1 diabetes EXPERT OPINION ON INVESTIGATIONAL DRUGS 2024
Obesity in type 1 diabetes: an overlooked immune-metabolic issue EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM 2024
No differences in kidney function decline between people with type 2 diabetes starting a sodium-glucose cotransporter 2 inhibitor or a glucagon-like peptide-1 receptor agonist: a real-world retrospective comparative observational study CLINICAL THERAPEUTICS 2024
Deterioration of Vestibular Motion Perception: A Risk Factor for Postural Instability and Falls in Elderly With Type 2 Diabetes DIABETES/METABOLISM RESEARCH AND REVIEWS 2024
Rethinking weight loss treatments as cardiovascular medicine in obesity, a comprehensive review EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY 2024
Younger-onset compared with later-onset type 2 diabetes: an analysis of the UK Prospective Diabetes Study (UKPDS) with up to 30 years of follow-up (UKPDS 92) THE LANCET DIABETES & ENDOCRINOLOGY 2024
Association of osteocalcin, osteoprotegerin, and osteopontin with cardiovascular disease and retinopathy in type 2 diabetes DIABETES/METABOLISM RESEARCH AND REVIEWS 2023
Impact of baseline kidney function on the effects of sodium-glucose co-transporter-2 inhibitors on kidney and heart failure outcomes: A systematic review and meta-analysis of randomized controlled trials DIABETES, OBESITY AND METABOLISM 2023
Relationship between Muscle Mass, Bone Density and Vascular Calcifications in Elderly People with SARS-CoV-2 Pneumonia JOURNAL OF CLINICAL MEDICINE 2023
Updates on Glycaemic Control Strategies: A Range of Opportunities after Total Pancreatectomy JOURNAL OF CLINICAL MEDICINE 2023
Lack of Association between Serum Chitotriosidase Activity and Arterial Stiffness in Type 2 Diabetes without Cardiovascular Complications INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2023

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma